Shenbai Jiedu Fang inhibits AOM/DSS-induced colorectal adenoma formation and carcinogenesis in mice via miRNA-22-mediated regulation of the PTEN/PI3K/AKT signaling pathway.
10.12122/j.issn.1673-4254.2022.10.03
- Author:
Jian Rong LIU
1
;
Wei Xing SHEN
1
;
Hai Bo CHENG
1
;
Min Min FAN
1
;
Jun XIAO
2
;
Chang Liang XU
1
;
Jia Ni TAN
1
;
Yue Yang LAI
1
;
Cheng Tao YU
1
;
Dong Dong SUN
1
;
Liu LI
1
Author Information
1. First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
2. Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210004, China.
- Publication Type:Randomized Controlled Trial, Veterinary
- Keywords:
AOM/DSS murine mode;
PTEN/PI3K/AKT signaling pathway;
Shenbai Jiedu Fang;
carcinogenesis;
colorectal adenoma;
miRNA-222
- MeSH:
Animals;
Male;
Mice;
Adenoma/prevention & control*;
Azoxymethane/adverse effects*;
Carcinogenesis/drug effects*;
Colorectal Neoplasms/prevention & control*;
Dextran Sulfate/adverse effects*;
Disease Models, Animal;
Glycogen Synthase Kinase 3 beta/metabolism*;
Mice, Inbred C57BL;
MicroRNAs/metabolism*;
Phosphatidylinositol 3-Kinases/metabolism*;
Proto-Oncogene Proteins c-akt/metabolism*;
Signal Transduction;
Drugs, Chinese Herbal/therapeutic use*
- From:
Journal of Southern Medical University
2022;42(10):1452-1461
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the inhibitory effect of Shenbai Jiedu Fang (SBJDF, a compound recipe of traditional Chinese herbal drugs) on chemically induced carcinogenesis of colorectal adenoma in mice and explore the role of PTEN/PI3K/AKT signaling pathway in mediating this effect.
METHODS:Four-week-old male C57BL/6 mice were randomly divided into control group (n=10), AOM/DSS model group (n=20), low-dose (14 g/kg) SBJDF group (n=10) and high-dose (42 g/kg) SBJDF group (n= 10). In the latter 3 groups, the mice were treated with azoxymethane (AOM) and dextran sodium sulphate (DSS) to induce carcinogenesis of colorectal adenoma. In the two SBJDF treatment groups, SBJDF was administered daily by gavage during the modeling. The survival rate, body weight, general condition of the mice, and intestinal adenoma formation and carcinogenesis were observed. The expressions of proteins associated with the PTEN/PI3K/AKT signaling pathway in the intestinal tissue were detected using immunohistochemistry.
RESULTS:Compared with those in the model group, the mice treated with SBJDF, especially at the high dose, showed a significantly lower incidence of intestinal carcinogenesis and had fewer intestinal tumors with smaller tumor volume. Pathological examination showed the occurrence of adenocarcinoma in the model group, while only low-grade and high-grade neoplasia were found in low-dose SBJDF group; the mice treated with high-dose SBJDF showed mainly normal mucosal tissues in the intestines with only a few lesions of low-grade neoplasia of adenoma. Compared with those in the control group, the mice in the model group had significantly elevated plasma miRNA-222 level (P < 0.05), which was obviously lowered in the two SBJDF groups (P < 0.01). The results of immunohistochemistry revealed that compared with the model group, the two SBJDF groups, especially the high-dose group, had significantly up-regulated expressions of PTEN, P-PTEN and GSK-3β and down-regulated expressions of p-GSK-3 β, PI3K, AKT, P-AKT, β-catenin, c-myc, cyclinD1 and survivin in the intestinal tissues.
CONCLUSION:SBJDF can significantly inhibit colorectal adenoma formation and carcino-genesis in mice possibly through regulating miRNA-222 and affecting PTEN/PI3K/AKT signaling pathway.
